Bakuna vs Ebola, posibleng isailalim sa clinical trial sa loob ng 2-3 months

Added: 2026-05-25

[00:00:02]Oxford University in United Kingdom of Congo and the the Democratic Republic of the Congo and the the Democratic Republic of the Congo at 750 suspected cases and 177 deaths. I am the World Health Organization. The Democratic Republic of the Democratic Republic of the Congo.

[00:00:41]The Ebola outbreak in the Democratic Republic of the Congo is spreading rapidly.

[00:00:47]Previously, WHO assesses the risk as high at the national and regional levels and low at global levels.

[00:00:57]We're now revising our risk assessment to very high at the national level, high at the regional level, and low at [music] global level.

[00:01:10]I am Bundibugyo Ebola strain.

[00:01:19]This epidemic is caused by Bundibugyo virus, a species of Ebola virus for which there are no approved vaccines or therapeutics.

[00:01:29]I expect it to Ebola.

[00:01:39]vaccine scientist COVID-19 vaccine pandemic. I don't know what it was in Shadow Swan technology. I don't know what I got modified common cold virus. I don't know what I trained on immune system lab on the Ebola.

[00:02:13]>> [music] >> It is possible that doses of that could be available for clinical trial in [music] two to three months, but there is a lot of uncertainty about that. And it will depend on the animal data as to whether that is considered a promising candidate research vaccine for Bundibugyo.

[00:02:48]>> [music] >> Patrolling the man on contact tracing quarantine [music] at the monitoring of the health authorities and the mama tiger in the virus.